EMERYVILLE, Calif., June 02, 2022 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq:GRTS), a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines, today announced that the company has been certified as a Great Place to Work by the Great Place to Work® Institute. Gritstone earned this highly desirable credential based on a comprehensive set of ratings provided by its employees in an anonymous survey. The award is based entirely on what current employees say about their experience working at Gritstone bio.
Gritstone Earns 2022 Great Place to Work Certification™
Globe Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here